Clinical Trial Update: Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining buprenorphine maintenance dose schedules and treatment settings for opioid-related and substance-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders
• Substance-related Disorders

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 2 | Status: COMPLETED